Sirius Genomics

Vancouver, Canada-based Sirius Genomics is using arrays to develop a test to identify individuals who respond to the hormone vasopressin and similar compounds for the treatment of septic shock.

The two firms will partner to develop diagnostics to identify individuals who respond well to Vasopressin and other compounds for the treatment of septic shock and related conditions.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Pairings

Premium

Kamran Alam, Stan Lapidus

Pairings

Premium

Chris Wagner, Brad Popovich, Jorge Garces, Greg Hamilton, Nick Williams, Darren Hall

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Sirius will work with a system of 37 hospitals to test biomarkers for severe sepsis drug response.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.